Advertisement
Screener

Anteris Technologies Global Corp. (AVR) Operating Income

Anteris Technologies Global Corp. Operating Income

Anteris Technologies Global Corp. (AVR) reported Operating Income of -$31.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-08-11

  • Anteris Technologies Global Corp. operating income (loss) for the quarter ending 2026-06-30 was -$31.00M.
  • Anteris Technologies Global Corp. operating income (loss) for the quarter ending 2026-03-31 was -$24.01M.
  • Anteris Technologies Global Corp. operating income (loss) for the quarter ending 2025-12-31 was -$28.96M.
  • Anteris Technologies Global Corp. operating income (loss) for the quarter ending 2025-09-30 was -$22.27M.
  • Anteris Technologies Global Corp. operating income (loss) for fiscal 2025 was -$93.89M.
  • Anteris Technologies Global Corp. operating income (loss) for fiscal 2024 was -$78.37M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 month
2026-06-30-$31.00M
10-Q · filed 2026-08-11
-$55.00M
10-Q · filed 2026-08-11
-$83.97M
derived: sum of 3 quarters · filed 2026-08-11
-$106.23M
derived: sum of 4 quarters · filed 2026-08-11
2026-03-31-$24.01M
10-Q · filed 2026-05-12
-$52.97M
derived: sum of 2 quarters · filed 2026-05-12
-$75.24M
derived: sum of 3 quarters · filed 2026-05-12
-$96.12M
derived: sum of 4 quarters · filed 2026-08-11
2025-12-31-$28.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$51.23M
derived: sum of 2 quarters · filed 2026-02-26
-$72.11M
derived: sum of 3 quarters · filed 2026-08-11
-$93.89M
10-K · filed 2026-02-26
2025-09-30-$22.27M
10-Q · filed 2025-11-12
-$43.15M
derived: sum of 2 quarters · filed 2026-08-11
-$64.93M
10-Q · filed 2025-11-12
-$86.45M
derived: sum of 4 quarters · filed 2026-08-11
2025-06-30-$20.88M
10-Q · filed 2026-08-11
-$42.66M
10-Q · filed 2026-08-11
-$64.18M
derived: sum of 3 quarters · filed 2026-08-11
-$84.78M
derived: sum of 4 quarters · filed 2026-08-11
2025-03-31-$21.78M
10-Q · filed 2026-05-12
-$43.30M
derived: sum of 2 quarters · filed 2026-05-12
-$63.90M
derived: sum of 3 quarters · filed 2026-05-12
-$82.37M
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31-$21.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$42.12M
derived: sum of 2 quarters · filed 2026-02-26
-$60.59M
derived: sum of 3 quarters · filed 2026-02-26
-$78.37M
10-K · filed 2026-02-26
2024-09-30-$20.60M
10-Q · filed 2025-11-12
-$39.07M
derived: sum of 2 quarters · filed 2025-11-12
-$56.85M
10-Q · filed 2025-11-12
2024-06-30-$18.47M
10-Q · filed 2025-08-11
-$36.26M
10-Q · filed 2025-08-11
2024-03-31-$17.79M
10-Q · filed 2025-05-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Enovis CORP (ENOV)United States$1.053B-1.18
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B
NutriBand Inc. (NTRB)United States$0.109B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
MYOMO, INC. (MYO)United States$0.065B-2.85
Envoy Medical, Inc. (COCH)United States$0.056B